TNF and inflammatory bowel disease: An inhibitorof TNF-α, infliximab (IFB), is an effective treatment of moderate to severeIBD, and polymorphisms in the TNF-α gene not only affect the phenotype of IBD, but may also impact IFBsusceptibility [8, 13].